Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1193813

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1193813

Autoinjectors

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 14850

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Autoinjectors Market to Reach $168.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Autoinjectors estimated at US$50.9 Billion in the year 2022, is projected to reach a revised size of US$168.2 Billion by 2030, growing at a CAGR of 16.1% over the analysis period 2022-2030. Rheumatoid Arthritis, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$47.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Anaphylaxis segment is readjusted to a revised 15.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $13.9 Billion, While China is Forecast to Grow at 21.4% CAGR

The Autoinjectors market in the U.S. is estimated at US$13.9 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$40.4 Billion by the year 2030 trailing a CAGR of 21.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.9% and 13.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$26.4 Billion by the year 2030.

Select Competitors (Total 42 Featured):

  • AbbVie, Inc.
  • Amgen, Inc.
  • Antares Pharma, Inc.
  • Becton, Dickinson and Company
  • Consort Medical PLC
  • Eli Lilly and Company
  • Haselmeier GmbH
  • Mylan NV
  • Owen Mumford Ltd.
  • SHL Group
  • Teva Pharmaceutical Industries Ltd.
  • Ypsomed AG
Show more
Product Code: MCP10421

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Rapid Shift from Self-Injectors to Autoinjectors for Easy and Safe Administration of Drugs Drives Demand
    • North America: The Largest Market for Autoinjectors
    • Autoinjectors - Global Key Competitors Percentage Market Share in 2022 (E)
    • Global Epinephrine Autoinjector market: Percentage Breakdown of Volume Sales by Leading Players for the Year 2019E
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Targeted Therapies such as Cancer, Rheumatoid Arthritis, Multiple Sclerosis and Diabetes: A Strong Growth Driver
    • Number of New Cases of Cancer Worldwide for the Years 2012, 2015, 2020, 2025 and 2030
    • Diabetes Prevalence in the Age-Group of 20-79 Years in Millions by Region for the Years 2018, 2021 and 2025
    • Global Injectable Drug Delivery Market: Revenues in US$ Billion for the Years 2016, 2018, 2020, 2022 and 2024
    • Rising Incidence of Anaphylaxis and Increased Prescription Rate of Epinephrine Autoinjectors Boosts Market Demand
    • Increasing Number of Regulatory Approvals for Autoinjectors in Various Diseases
    • Generic Autoinjectors Take Center Stage
    • Patent Expiry of Biologics to Drive the Demand for Biosimilars
    • Strong Government Support and Favorable Reimbursement Policies Propel Market Growth
    • Challenges
    • Development of Autoinjectors for Multiple Drug Viscosities: A Major Challenge
    • Increasing Demand for Alternative Drug Delivery Modes Hampers Market Growth
    • Emergence of Oral Diabetic Agents, Oral Insulin and Epinephrine Nasal Sprays Poses Huge Challenge for Autoinjectors Market
    • Product Overview
    • Autoinjector: Definition
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Rheumatoid Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Rheumatoid Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Rheumatoid Arthritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Multiple Sclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Anaphylaxis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Anaphylaxis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Anaphylaxis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Autoinjectors Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Disposable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Disposable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Disposable Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Reusable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Reusable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Reusable Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Ambulatory Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • JAPAN
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • CHINA
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: China 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: China 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • EUROPE
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Autoinjectors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • FRANCE
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: France 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: France 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: France 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • GERMANY
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Autoinjectors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • INDIA
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: India 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: India 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: India 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Autoinjectors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Autoinjectors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030
  • AFRICA
    • Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2023 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2023 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!